Cargando…
Improving Access to Medicines in Low and Middle Income Countries: Corporate Responsibilities in Context
More than two billion people in low- and middle-income countries (LMIC) lack adequate access to essential medicines. In this paper, we make strong public health, human rights and economic arguments for improving access to medicines in LMIC and discuss the different roles and responsibilities of key...
Autores principales: | Leisinger, Klaus Michael, Garabedian, Laura Faden, Wagner, Anita Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dr. Zaheer-Ud-Din Babar
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606933/ https://www.ncbi.nlm.nih.gov/pubmed/23535994 |
Ejemplares similares
-
Using ‘smart regulation’ to tackle antimicrobial resistance in low-income and middle-income countries
por: Porter, Gerard, et al.
Publicado: (2020) -
Cochrane corner: community-level interventions to increase access to food in low- and middle-income countries
por: Durão, Solange, et al.
Publicado: (2022) -
Europe should lead in coordinated procurement of quality-assured medicines for programmes in low-income and middle-income countries
por: Perrin, Christophe, et al.
Publicado: (2020) -
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
por: Ravinetto, Raffaella, et al.
Publicado: (2016) -
Achieving affordable critical care in low-income and middle-income countries
por: Turner, Hugo C, et al.
Publicado: (2019)